The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preferences among patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM) in the era of B-cell maturation antigen (BCMA)-directed T-cell–engaging therapies.
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen (Inst); Beigene; BMS (Inst); Cellectar (Inst); GlaxoSmithKline; Janssen (Inst); Pharmacyclics (Inst); Regeneron; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Ascentage Pharma (Inst); BMS (Inst); Cellectar (Inst); GlaxoSmithKline (Inst); Janssen Biotech (Inst); Pharmacyclics (Inst); Sanofi (Inst)
 
Timothy J. Inocencio
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Carol Mansfield
No Relationships to Disclose
 
Phani Chintakayala
No Relationships to Disclose
 
Cooper Bussberg
Other Relationship - RTI Health Solutions
 
Lei Chi
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
James Harnett
Employment - Regeneron
Stock and Other Ownership Interests - Pfizer; Regeneron
 
Glenn Scott Kroog
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Research Funding - Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Yariv Houvras
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Karen Rodriguez-Lorenc
Employment - Regeneron
Stock and Other Ownership Interests - Novartis; Regeneron
 
Qiufei Ma
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron